Ocugen, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) concerning whether a series of statements by Ocugen, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Malvern, PA based Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases.
On May 26, 2021, Ocugen, Inc. announced its plan to submit an Emergency Use Authorization (EUA) application for COVAXIN, a COVID-19 vaccine, to the U.S. Food & Drug Administration (FDA) in June 2021.
Then on June 10, 2021, Ocugen, Inc. said it would no longer pursue a EUA for Covaxin and would instead aim to file for a full U.S. approval of the shot.
Shares of Ocugen, Inc. (NASDAQ: OCGN) declined from $11.01 per share on June 8, 2021 to $5.96 per share on June 14, 2021.
Those who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North
San Diego, CA 92108
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.